![Matthew Lang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Lang
Chief Operating Officer at
STRUCTURE THERAPEUTICS INC.
Net worth: 3 M $ as of 30/06/2026
Profile
Mr. Matthew Lang is a Chief Operating Officer & General Counsel at Structure Therapeutics, Inc. Mr. Lang was previously employed as a Chief Legal Officer & Secretary by Metsera, Inc., a Secretary, Chief Legal & Business Officer by Lyell Immunopharma, Inc., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences Ltd., a Secretary, Chief Administrative & Legal Officer by Myovant Sciences, Inc., a VP & Head- Global Litigation & Investigations by Gilead Sciences, Inc., an Attorney by Dechert LLP, and a Chairman-Management Board by Sumitomo Pharma Switzerland GmbH.
He also served on the board at United Way of the Bay Area.
He received his undergraduate degree from Queen's University and a graduate degree from The University of Pennsylvania Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/04/2026 | 184,614 ( 0.13% ) | 3 M $ | 30/06/2026 |
Matthew Lang active positions
| Companies | Position | Start |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Chief Operating Officer | 15/04/2026 |
Former positions of Matthew Lang
| Companies | Position | End |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | General Counsel | 13/04/2025 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Chief Administrative Officer | 01/01/2023 |
United Way of the Bay Area
 United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Director/Board Member | 01/01/2018 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/07/2017 |
Training of Matthew Lang
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
91
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dechert LLP
 Dechert LLP Miscellaneous Commercial ServicesCommercial Services Operates as a law firm | Commercial Services |
United Way of the Bay Area
United Way of the Bay Area Miscellaneous Commercial ServicesCommercial Services Owns and operates charities | Commercial Services |
The University of Pennsylvania Law School
 The University of Pennsylvania Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Myovant Sciences GmbH
 Myovant Sciences GmbH BiotechnologyHealth Technology Engages in development and marketing of biopharmaceutical products | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Structure Therapeutics, Inc.
 Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
- Stock Market
- Insiders
- Matthew Lang
